Literature DB >> 18230026

Expression and regulation of major histocompatibility complex on neural stem cells and their lineages.

Lan Yin1, Sai-Li Fu, Gui-Ying Shi, Ying Li, Jian-Qiang Jin, Zheng-Wen Ma, Pei-Hua Lu.   

Abstract

The expression of major histocompatibility complex (MHC) antigens on neural stem cells (NSCs) and their lineages is tightly related to the fate of these cells as grafts in allogenic transplantation. In this study, we observed that NSCs derived from embryonic rat forebrain expressed MHC class I and class II molecules at a low level, whereas the cells differentiated from NSCs, including neurons, astrocytes, and oligodendrocytes, lost their MHC expression. However, a proinflammatory factor, interferon-gamma (IFN-gamma), could induce and up-regulate the expression of MHC in both NSCs and their differentiated lineages in vitro. These results suggest that predifferentiating NSCs into lineage-limited cells prior to transplantation combined with controlling the local production of proinflammatory cytokines moderately may potentially benefit the survival of transplants.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18230026     DOI: 10.1089/scd.2007.0063

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  13 in total

Review 1.  Sensing the microenvironment of the central nervous system: immune cells in the central nervous system and their pharmacological manipulation.

Authors:  Zsuzsanna Fabry; Heidi A Schreiber; Melissa G Harris; Matyas Sandor
Journal:  Curr Opin Pharmacol       Date:  2008-09-02       Impact factor: 5.547

2.  Achieving stable human stem cell engraftment and survival in the CNS: is the future of regenerative medicine immunodeficient?

Authors:  Aileen J Anderson; Daniel L Haus; Mitra J Hooshmand; Harvey Perez; Christopher J Sontag; Brian J Cummings
Journal:  Regen Med       Date:  2011-05       Impact factor: 3.806

3.  Effect of central myelin on the proliferation and differentiation into O4(+) oligodendrocytes of GFP-NSCs.

Authors:  Chao-Jin Xu; Yang Wang; Min Liao
Journal:  Mol Cell Biochem       Date:  2011-07-01       Impact factor: 3.396

4.  Long-term fate of allogeneic neural stem cells following transplantation into injured spinal cord.

Authors:  Liang Xu; Chao-jin Xu; He-Zuo Lü; Yan-Xia Wang; Ying Li; Pei-Hua Lu
Journal:  Stem Cell Rev Rep       Date:  2010-03       Impact factor: 5.739

Review 5.  Cell migration in the normal and pathological postnatal mammalian brain.

Authors:  Myriam Cayre; Peter Canoll; James E Goldman
Journal:  Prog Neurobiol       Date:  2009-02-11       Impact factor: 11.685

6.  Gone over to the dark side: Natalizumab-associated JC virus infection of neurons in cerebellar gray matter.

Authors:  Xin Dang; Igor J Koralnik
Journal:  Ann Neurol       Date:  2013-10       Impact factor: 10.422

7.  Neural stem/progenitor cells as a promising candidate for regenerative therapy of the central nervous system.

Authors:  Virginie Bonnamain; Isabelle Neveu; Philippe Naveilhan
Journal:  Front Cell Neurosci       Date:  2012-04-11       Impact factor: 5.505

Review 8.  Stem cell-based therapies for ischemic stroke.

Authors:  Lei Hao; Zhongmin Zou; Hong Tian; Yubo Zhang; Huchuan Zhou; Lei Liu
Journal:  Biomed Res Int       Date:  2014-02-26       Impact factor: 3.411

9.  Identification by automated screening of a small molecule that selectively eliminates neural stem cells derived from hESCs but not dopamine neurons.

Authors:  Yi Han; Aaron Miller; Julie Mangada; Ying Liu; Andrzej Swistowski; Ming Zhan; Mahendra S Rao; Xianmin Zeng
Journal:  PLoS One       Date:  2009-09-23       Impact factor: 3.240

Review 10.  Immunological barriers to stem cell therapy in the central nervous system.

Authors:  Gregory E Tullis; Kathleen Spears; Mark D Kirk
Journal:  Stem Cells Int       Date:  2014-08-05       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.